Literature DB >> 17868955

Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.

Krzysztof Sztanke1, Kazimierz Pasternak, Jolanta Rzymowska, Małgorzata Sztanke, Martyna Kandefer-Szerszeń.   

Abstract

Synthesis, structure elucidation and anticancer activities of novel fused 1,2,4-triazine aryl derivatives containing the ethoxycarbonyl (6-10) and carbohydrazide formations (11-15) are presented. Molecular structures of the synthesized compounds were confirmed by IR, (1)H NMR, (13)C NMR, EI-MS spectra and elemental analyses. Antitumour activities in vitro for heterobicyclic hydrazides of the type 11-14 were evaluated by BrdU method for human LS180, SiHa and T47D carcinoma cells. Amongst them, hydrazide 14 has exhibited remarkable inhibitory effect against SiHa and LS180 tumour cells, and simultaneously was found to be non-toxic towards the human normal cell line-HSF cells. Furthermore, the pulse field gel electrophoresis experiment was performed for characterizing DNA-cleaving activity of heterobicycle 14. The DNA fragments of 2500, 2000 and 500 kilobase pairs (kbp) were commonly detected in the cancer cell lines (SiHa, LS180 and T47D) treated with compound 14. DNA fragmentation pattern, since three types of fragments induced by the tested hydrazide of the type 14 were detected, suggesting a way of interaction with DNA. It is worth pointing out, that DNA strand breaks were also produced in human breast cancer (T47D) cells, a cell line where the induction of DNA fragmentation is very difficult. Moreover, the statistically significant apoptotic activity in T47D human breast cancer cells for the tested heterobicycle 14 was proved using the annexin V-binding assay. The antiproliferative properties in vitro for compounds 6-14 were evaluated by MTT method for human leukaemic Jurkat cells. Significant viability decreases in Jurkat cells treated with different concentrations of compounds 10 and 11 were observed, suggesting that these derivatives have antiproliferative activities. Their acute toxicities were established. For these compounds the influence on the central nervous system of mice in behavioural tests was examined. Molecular structure for free base of the intermediate 4 was confirmed by (1)H-(1)H COSY, HMBC and HMQC correlations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17868955     DOI: 10.1016/j.ejmech.2007.07.009

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  A novel triazole, NMK-T-057, induces autophagic cell death in breast cancer cells by inhibiting γ-secretase-mediated activation of Notch signaling.

Authors:  Amlan Das; Maruthi Kumar Narayanam; Santanu Paul; Pritha Mukhnerjee; Suvranil Ghosh; Debabrata Ghosh Dastidar; Subhendu Chakrabarty; Arnab Ganguli; Biswarup Basu; Mahadeb Pal; Urmi Chatterji; Sushanta K Banerjee; Parimal Karmakar; Dalip Kumar; Gopal Chakrabarti
Journal:  J Biol Chem       Date:  2019-03-01       Impact factor: 5.157

2.  In vitro effects of a new fused azaisocytosine-like congener on relative cell proliferation, necrosis and cell cycle in cancer and normal cell cultures.

Authors:  Małgorzata Sztanke; Jolanta Rzymowska; Krzysztof Sztanke
Journal:  Mol Cell Biochem       Date:  2016-06-23       Impact factor: 3.396

3.  Biologically important hydrazide-containing fused azaisocytosines as antioxidant agents.

Authors:  Małgorzata Sztanke; Krzysztof Sztanke
Journal:  Redox Rep       Date:  2017-08-16       Impact factor: 4.412

4.  Synthesis of Novel Pyrido[4,3-e][1,2,4]triazino[3,2-c][1,2,4]thiadiazine 6,6-dioxide Derivatives with Potential Anticancer Activity.

Authors:  Jarosław Sławiński; Aleksandra Grzonek; Beata Żołnowska; Anna Kawiak
Journal:  Molecules       Date:  2015-12-29       Impact factor: 4.411

5.  Synthesis and Pharmacological Studies of Unprecedented Fused Pyridazino[3',4':5,6][1,2,4]triazino[3,4-b][1,3,4]thiadiazine Derivatives.

Authors:  Rania S Ali; Hosam A Saad
Journal:  Molecules       Date:  2018-04-27       Impact factor: 4.411

Review 6.  Bile Acid Conjugates with Anticancer Activity: Most Recent Research.

Authors:  Maria Luisa Navacchia; Elena Marchesi; Daniela Perrone
Journal:  Molecules       Date:  2020-12-23       Impact factor: 4.411

7.  Regioselective synthesis of 7,8-dihydroimidazo[5,1-c][1,2,4]triazine-3,6(2H,4H)-dione derivatives: A new drug-like heterocyclic scaffold.

Authors:  Nikolay T Tzvetkov; Harald Euler; Christa E Müller
Journal:  Beilstein J Org Chem       Date:  2012-09-20       Impact factor: 2.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.